Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Research has undertaken research on the potential impact of psychedelic medication on the treatment of severe mental health conditions.

The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is supporting psilocybin research via the NIHR King’s Clinical Research Facility and the NIHR Maudsley Biomedical Research Centre, where researchers are developing and evaluating the efficacy and safety of psilocybin therapy for use in the National Health Service and other healthcare settings. The NIHR continues to welcome funding applications for research into any aspect of human health, including research on the potential impact of psychedelic substances for the treatment of severe mental health conditions.